top of page
Profile
Join date: Apr 7, 2025
Posts (4)
May 21, 2025 ∙ 2 min
3R Pharma Ltd. Announces the Appointment of Prof. Boris Knaizer to its Scientific Advisory Board
June 22, 2023 – Yeruham, Israel: 3R Pharma Ltd., a preclinical-stage pharmaceutical company focused on developing novel cannabinoid-based...
5
0
May 21, 2025 ∙ 2 min
3R Pharma Ltd. Announces the Appointment of Prof. Avi Solomon to its Scientific Advisory Board
2.23.2023, Yeruham, Israel - 3R Pharma Ltd, a preclinical-stage pharmaceutical company-up focused on developing novel cannabinoid-based...
0
0
May 21, 2025 ∙ 2 min
3R Pharma Receives Follow-On Investment from The Israeli Innovation Authority and CanNegev Incubator to Accelerate Cannabinoids-based Ophthalmic Drug Development
[19.02.2023 Yeruham, Israel] - 3R Pharma Ltd, a preclinical pharmaceutical company focused on developing novel cannabinoid-based...
3
0
Michael Rubinov
Admin
More actions
bottom of page